MustGrow Biologics Corp. (MGROF)

Market Cap	29.14M -48.2%
Revenue (ttm)	5.41M +51.0%
Net Income	-4.57M
EPS	-0.09
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	5,169
Open	0.4688
Previous Close	0.4770
Day's Range	0.4688 - 0.4688
52-Week Range	0.3655 - 1.0210
Beta	0.67
RSI	46.24
Earnings Date	Apr 23, 2026

About MustGrow Biologics

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard plants. The company provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 2014
• Country: Canada
• Stock Exchange: OTCMKTS
• Ticker Symbol: MGROF

Financial Performance

In 2024, MustGrow Biologics's revenue was 398,018, a decrease of -91.55% compared to the previous year's 4.71 million. Losses were -4.89 million, 622.2% more than in 2023.

Financial numbers in CAD